XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 851,660 $ 21,952,000 $ 2,176   $ 39,819,420 $ (31,590,583) $ 31,034,673
Balance (in Shares) at Dec. 31, 2022 170,332 21,952 21,750,804        
Provision for compensation expense related to stock-based compensation   420,748 420,748
Exercise of stock options into common stock   1,185 1,185
Exercise of stock options into common stock (in Shares)     1,500        
Net loss   (230,215) (230,215)
Balance at Mar. 31, 2023 $ 851,660 $ 21,952,000 $ 2,176   40,241,353 (31,820,798) 31,226,391
Balance (in Shares) at Mar. 31, 2023 170,332 21,952 21,752,304        
Balance at Dec. 31, 2023 $ 851,660 $ 21,952,000 $ 2,176 $ (166,757) 42,415,894 (35,824,200) 29,230,773
Balance (in Shares) at Dec. 31, 2023 170,332 21,952 21,752,304 164,029      
Provision for compensation expense related to stock-based compensation 217,125 217,125
Purchases of treasury stock $ (6,098) (6,098)
Purchases of treasury stock (in Shares)       5,418      
Net loss (214,179) (214,179)
Balance at Mar. 31, 2024 $ 851,660 $ 21,952,000 $ 2,176 $ (172,855) $ 42,633,019 $ (36,038,379) $ 29,227,621
Balance (in Shares) at Mar. 31, 2024 170,332 21,952 21,752,304 169,447